Ferrari, Vittorio <br/><br/>
Gemcitabine plus celecoxib (GECO) in advanced pancreatic cancer: a phase II trial.  [electronic resource] 

 -  Cancer chemotherapy and pharmacology  Jan 2006 
 - 185-90 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article 
<br/><br/><label>ISSN: </label>0344-5704 
<br/><br/><label>Standard No.: </label>10.1007/s00280-005-0028-1  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenocarcinoma--drug therapy<br/>Administration, Oral<br/>Adult<br/>Aged<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Celecoxib<br/>Deoxycytidine--administration & dosage<br/>Female<br/>Humans<br/>Infusions, Intravenous<br/>Male<br/>Middle Aged<br/>Pancreatic Neoplasms--drug therapy<br/>Pyrazoles--administration & dosage<br/>Sulfonamides--administration & dosage<br/>Survival Analysis<br/>Treatment Outcome<br/>Gemcitabine